A Cleveland, Tennessee, woman was invited to attend Thursday’s State of the Union address as a special guest of U.S. Rep. Buddy Carter, R-Georgia, to raise awareness of sickle cell disease and treatment.
Jennelle Stephenson, a behavioral analyst who moved to Cleveland in September, has lived with sickle cell her entire life. Six years ago, she participated in a clinical trial for a gene therapy touted as a potentially curative treatment for the disease. In December, that gene therapy, lyfgenia by biotechnology company Bluebird Bio, received approval from the Food and Drug Administration.
Stephenson traveled to the nation’s capitol to speak with government officials about sickle cell and inform them of the new gene therapy, advocating for accessibility to the treatment now that it has received approval.
“They were so excited and just so happy that something was being done in the community for sickle cell disease, and they were responsive and receptive to, yes, this needs to be accessible,” Stephenson said by phone Friday. “So, I thought it went very well.”




